Combination vaccine against diptheria, tetanus, pertussis (acellular) and polio (dTP-polio) to booster vaccination to be used in the Norwegian child vaccination program.

Hange

Avatud menetlus
19.02.2014 5:34 (GMT+02:00)

Hankija

Nasjonalt folkehelseinstitutt983744516 Nasjonalt folkehelseinstitutt983744516
Lovisenberggata 8
0456 Oslo
Norra

Eesmärk

Open tender competition for purchase of combination vaccine again diptheria, tetanus, pertussis (acellular) and polio (dTP-polio) to booster vaccination to be used in the Norwegian child vaccination program.

The competition is carried out as an open competitive tender, a one step process where all interested suppliers may submit a tender. Negotiations are not allowed.

Section V: Award of contract

Contract No: 1

Lot No: 1 - Lot title: Supply agreement for 2013 and 2014 with options for 2015 and 2016.

V.1) Date of contract award decision:

V.2) Information about offers

Number of offers received: 2

V.3) Name and address of economic operator in favour of whom the contract award decision has been taken

GlaxoSmithKline AS, Postboks 180, Vinderen, 0319 Oslo, NORWAY

Mercell Estonia OÜ

Mercelli gruppi kuuluv Euroopa juhtiv e-hanke keskkond vahendab infot ostjate ja tarnijate vahel.

Kontakt

Mercell Eesti kasutajatugi

+372 683 6785
Mercell Estonia OÜ | Põhja puiestee 21C, 10143 Tallinn, Eesti